Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alembic Pharma Alembic Pharmaceuticals Ltd. | BSE 764.85 -5.35 (-0.69%) | NSE 765.15 -4.65 (-0.60%) | Trade | Add

BSE Live

Jan 20, 14:41

764.85 -5.35 (-0.69%)

Volume

AVERAGE VOLUME

5-Day

2,953

10-Day

3,762

30-Day

3,842

5,467

Prev. Close

770.20
Open Price

769.05

Bid Price (Qty.)
767.00 (3)
Offer Price (Qty.)
768.60 (12)

NSE Live

Jan 20, 14:41

765.15 -4.65 (-0.60%)

Volume

AVERAGE VOLUME

5-Day

54,992

10-Day

68,772

30-Day

57,204

47,914

Prev. Close

769.80
Open Price

769.90

Bid Price (Qty.)
767.75 (5)
Offer Price (Qty.)
768.05 (5)

Financials

Print/Copy to Excel : Go

Balance Sheet of Alembic Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	37.70	37.70	37.70	37.70	37.70
Total Share Capital	37.70	37.70	37.70	37.70	37.70
Reserves and Surplus	3,308.32	2,674.71	2,156.93	1,829.62	1,492.58
Total Reserves and Surplus	3,308.32	2,674.71	2,156.93	1,829.62	1,492.58
Total Shareholders Funds	3,346.02	2,712.41	2,194.63	1,867.32	1,530.28
NON-CURRENT LIABILITIES
Long Term Borrowings	886.99	499.30	500.00	0.00	0.00
Deferred Tax Liabilities [Net]	45.76	45.27	44.64	43.78	50.02
Other Long Term Liabilities	73.30	0.00	0.00	12.57	13.05
Long Term Provisions	73.21	51.33	61.33	57.22	28.23
Total Non-Current Liabilities	1,079.26	595.90	605.97	113.57	91.30
CURRENT LIABILITIES
Short Term Borrowings	800.04	359.98	121.53	0.00	0.00
Trade Payables	393.17	529.91	601.98	465.82	500.21
Other Current Liabilities	222.11	318.46	140.28	48.77	51.32
Short Term Provisions	38.17	32.37	13.50	12.30	16.00
Total Current Liabilities	1,453.49	1,240.72	877.29	526.89	567.53
Total Capital And Liabilities	5,878.77	4,549.03	3,677.89	2,507.78	2,189.11
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,268.11	1,077.08	918.30	799.01	697.25
Intangible Assets	0.00	0.00	0.00	0.00	0.00
Capital Work-In-Progress	1,569.98	1,106.89	740.64	347.75	92.34
Other Assets	8.35	8.35	0.00	0.00	0.00
Fixed Assets	2,846.44	2,192.32	1,658.94	1,146.76	789.59
Non-Current Investments	833.25	506.39	298.89	103.04	37.46
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	36.52	48.75
Other Non-Current Assets	47.71	14.31	44.37	0.00	0.00
Total Non-Current Assets	3,727.40	2,713.02	2,002.20	1,286.32	875.80
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	1,073.19	891.41	669.93	574.62	533.72
Trade Receivables	784.11	539.75	621.66	466.06	371.50
Cash And Cash Equivalents	37.13	150.80	15.63	0.69	284.81
Short Term Loans And Advances	0.00	0.00	0.00	20.19	123.28
OtherCurrentAssets	256.94	254.05	368.47	159.90	0.00
Total Current Assets	2,151.37	1,836.01	1,675.69	1,221.46	1,313.31
Total Assets	5,878.77	4,549.03	3,677.89	2,507.78	2,189.11
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	455.59	409.05	317.89	394.77	0.00
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	328.30
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	4.81
Trade/Other Goods	0.00	0.00	0.00	0.00	4.81
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	606.20	606.48	0.00	0.00	196.35
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	1,755.08
Other Earnings	2,180.77	1,945.27	--	--	25.97
BONUS DETAILS
Bonus Equity Share Capital	--	--	--	--	--
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	833.25	506.39	298.89	103.04	37.46
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--